视网膜中央动脉阻塞患者就医延迟研究进展

doi:10.3761/j.issn.1672-9234.2025.03.019

摘要/Abstract

摘要：

就医延迟（包括院前延迟和院内延迟）是导致视网膜中央动脉阻塞患者溶栓率低的主要原因。该文对视网膜中央动脉阻塞患者就医延迟的概念内涵及就医延迟影响因素等进行综述。视网膜中央动脉阻塞患者就医院前延迟影响因素包括人口统计学因素、症状感知水平、认知和相关知识水平、就诊和转运模式；院内延迟影响因素包括医疗资源有限和水平不足、院间转诊未成体系、缺乏相关标准化救治流程。建议将单眼突发性无痛性视力丧失纳入院前卒中评估，提高公众对疾病的识别度；构建视网膜中央动脉阻塞绿色通道，缩短到院至溶栓时间，进而改善视网膜中央动脉阻塞患者就医延迟的状况。

关键词: 视网膜中央动脉阻塞, 就医延迟, 综述

Abstract:

Medical delay （including pre-hospital and in-hospital delay） is the main cause for the low thrombolytic rate in patients with central retinal artery occlusion. In this paper，we described the concept of medical delay and reviewed the influencing factors. The influencing factors of prehospital delay included demographic factors，symptom perception level，awareness and related knowledge level，visit and transport mode. Through reviewing，limited and inadequate medical resources，incomplete inter-hospital referral system，and lack of standardized treatment procedures were found to be the factors affecting in-hospital delay. After analysis，this paper suggested that sudden painless vision loss in one eye should be included in prehospital stroke assessment to improve public recognition of the disease. Besides，constructing the green channel of central retinal artery occlusion，speeding up the pre-diagnosis triage，diagnosis and treatment，shortening the time from door to needle were recommended to provide reference for improving the medical delay of patients with central retinal artery occlusion in the future.

Key words: Central retinal artery occlusion, Medical delay, Literature Review

邱丽欢, 梁安怡, 欧阳淑怡. 视网膜中央动脉阻塞患者就医延迟研究进展[J]. 中华护理教育, 2025, 22(3): 379-384.

QIU Lihuan, LIANG Anyi, OUYANG Shuyi. Review of medical delay in patients with central retinal artery occlusion[J]. Chinese Journal of Nursing Education, 2025, 22(3): 379-384.

参考文献 37

[1]	Mac Grory B, Schrag M, Biousse V, et al. Management of central retinal artery occlusion:a scientific statement from the American heart association[J]. Stroke, 2021, 52(6):e282-e294.
[2]	邵毅, 谭思文, 肖昂. 视网膜中央动脉阻塞诊疗规范:2021美国心脏协会指南解读[J]. 眼科新进展, 2021, 41(10):901-904.
[3]	Flowers AM, Chan W, Meyer BI, et al. Referral patterns of central retinal artery occlusion to an academic center affiliated with a stroke center[J]. J Neuroophthalmol, 2021, 41(4):480-487.
[4]	Wolfe SQ, Coffman SA, Perez M, et al. Multidisciplinary acute care of central retinal artery occlusion with a stroke paradigm:a call to action[J]. Arch Clin Ophthalmol, 2021, 1(1):20-26.
[5]	许晓晗, 吴迪, 高渊, 等. 动脉内溶栓治疗视网膜中央动脉阻塞的研究进展[J]. 国际眼科杂志, 2023, 23(9):1486-1489.
	Xu XH, Wu D, Gao Y, et al. Research progress on intra-arterial thrombolysis for the treatment of central retinal artery occlusion[J]. Int Eye Sci, 2023, 23(9):1486-1489.
[6]	袁航, 谢立科, 罗傑, 等. 视网膜动脉阻塞危险因素和治疗的研究现状[J]. 国际眼科杂志, 2021, 21(3):446-449.
[7]	Smith MJ, Benson MD, Tennant M, et al. Central retinal artery occlusion:a retrospective study of disease presentation,treat-ment,and outcomes[J]. Can J Ophthalmol, 2023, 58(4):318-323.
[8]	Biousse V, Nahab F, Newman NJ. Management of acute retinal ischemia:follow the guidelines！[J]. Ophthalmology, 2018, 125(10):1597-1607.
[9]	Wai KM, Knapp A, Ludwig CA, et al. Risk of stroke,myocardial infarction,and death after retinal artery occlusion[J]. JAMA Ophthalmol, 2023, 141(12):1110-1116.
[10]	Chan W, Flowers AM, Meyer BI, et al. Acute central retinal artery occlusion seen within 24 hours at a tertiary institution[J]. J Stroke Cerebrovasc Dis, 2021, 30(9):105988.
[11]	Shah R, Gilbert A, Melles R, et al. Central retinal artery oc-clusion:time to presentation and diagnosis[J]. Ophthalmol Retina, 2023, 7(6):527-531.
[12]	Kozner P, Eichenmann L, Burdova MC, et al. Long-term out-comes of intravenous fibrinolysis in central retinal artery occlusion[J]. Sci Rep, 2023, 13(1):20505.
[13]	Stretz C, Paddock JE, Burton TM, et al. IV Thrombolysis for central retinal artery occlusion. Real-world experience from a comprehensive stroke center[J]. J Stroke Cerebrovasc Dis, 2024, 33(4):107610.
[14]	刘琴琴, 杨丽, 赵秋利, 等. 缺血性卒中溶栓就医延迟风险因素研究进展[J]. 中国全科医学, 2019, 22(16):2000-2007. doi: 10.12114/j.issn.1007-9572.2019.00.132
[15]	李会仿, 杨丽, 李妮娜, 等. 急性脑卒中患者就医延迟影响因素研究进展[J]. 护理学杂志, 2018, 33(16):98-101.
[16]	邹浩, 姜东旭, 张琳琳. 慢性病患者就医延迟评估工具及影响因素的研究进展[J]. 中国全科医学, 2022, 25(7):893-898.
[17]	Liu WS, Bai D, Kou LL. Progress in central retinal artery occlusion:a narrative review[J]. J Int Med Res, 2023, 51(9):3000605231198388.
[18]	Alex Ochakovski G, Wenzel DA, Spitzer MS, et al. Retinal oedema in central retinal artery occlusion develops as a function of time[J]. Acta Ophthalmol, 2020, 98(6):e680-e684.
[19]	Hoyer C, Winzer S, Matthé E, et al. Current diagnosis and treatment practice of central retinal artery occlusion:results from a survey among German stroke units[J]. Neurol Res Pract, 2022, 4(1):30.
[20]	Casagrande M, Steinhorst NA, Dippel SK, et al. Central retinal artery occlusion - detection score[J]. Front Med, 2023,10:1129002.
[21]	Schrag M, Youn T, Schindler J, et al. Intravenous fibrinolytic therapy in central retinal artery occlusion:a patient-level meta-analysis[J]. JAMA Neurol, 2015, 72(10):1148-1154.
[22]	何珂, 张鹏. 视网膜中央动脉阻塞的治疗进展[J]. 国际眼科杂志, 2024, 24(3):411-414.
	He K, Zhang P. Progress in the treatment of central retinal artery occlusion[J]. Int Eye Sci, 2024, 24(3):411-414.
[23]	Lee KE, Tschoe C, Coffman SA, et al. Management of acute central retinal artery occlusion,a “retinal stroke”:an institu-tional series and literature review[J]. J Stroke Cerebrovasc Dis, 2021, 30(2):105531.
[24]	Jurado EA, Sturm V, Brugger F, et al. Central retinal artery occlusion:current practice,awareness and prehospital delays in Switzerland[J]. Front Neurol, 2022,13:888456.
[25]	Hoyer C, Kahlert C, Güney R, et al. Central retinal artery oc-clusion as a neuro-ophthalmological emergency:the need to raise public awareness[J]. Eur J Neurol, 2021, 28(6):2111-2114.
[26]	周杰, 郭珍妮, 姜宇, 等. 从缺血性卒中角度再看视网膜中央动脉阻塞[J]. 安徽医科大学学报, 2024, 59(4):721-725.
[27]	Chen CL, Singh G, Madike R, et al. Central retinal artery occ-lusion:a stroke of the eye[J]. Eye, 2024, 38(12):2319-2326.
[28]	Sharma RA, Dattilo M, Newman NJ, et al. Treatment of nonar-teritic acute central retinal artery occlusion[J]. Asia Pac J Ophthalmol, 2018, 7(4):235-241.
[29]	Uhr JH, Mishra K, Wei C, et al. Awareness and knowledge of emergent ophthalmic disease among patients in an internal medicine clinic[J]. JAMA Ophthalmol, 2016, 134(4):424-431. doi: 10.1001/jamaophthalmol.2015.6212 pmid: 26892039
[30]	章琛越, 朱雪娇. 减少脑卒中患者延迟就医行为健康教育的研究进展[J]. 中华护理教育, 2021, 18(8):759-764.
	Zhang CY, Zhu XJ. Research progress of health education related to reducing delay of treatment behavior in stroke patients[J]. Chin J Nurs Educ, 2021, 18(8):759-764.
[31]	Schultheiβ M, Steinhorst NA, Dippel S, et al. Diagnosing central retinal artery occlusion(CRAO) without fundus examination[J]. Klin Monbl Augenheilkd, 2022, 239(3):288-292.
[32]	梁安怡, 牛勇毅, 吴乔伟, 等. 基于眼卒中绿色通道的眼动脉内介入溶栓治疗视网膜动脉阻塞的有效性和安全性研究[J]. 中华眼底病杂志, 2023, 39(6):444-450.
	Liang AY, Niu YY, Wu QW, et al. Efficacy and safety of intra-arterial thrombolysis for retinal artery occlusion based on the green channel for eye stroke[J]. Chin J Ocul Fundus Dis, 2023, 39(6):444-450.
[33]	赵楠, 吴雅琼, 杨文艺, 等. 眼-脑卒中“双轨并行” 治疗在视网膜中央动脉阻塞患者溶栓中的应用[J]. 暨南大学学报(自然科学与医学版), 2023, 44(3):267-273.
[34]	Lin JC, Song SL, Ng SM, et al. Treatments for acute nonar-teritic central retinal artery occlusion:findings from a coch-rane systematic review[J]. Ophthalmic Surg Lasers Imaging Retina, 2023, 54(11):650-653.
[35]	Caja KR, Griffith KM, Roth KR, et al. Detection of central re-tinal artery occlusion by point-of-care ultrasound in the emergency department:a case series[J]. Cureus, 2021, 13(7):e16142.
[36]	Bourguignon GH, Hupin N, Otjacques L, et al. Early OCT-angio-graphy findings lead to prompt intravenous thrombolysis and good visual recovery in central retinal artery occlusion:a case report[J]. J Fr Ophtalmol, 2024, 47(4):104032.
[37]	Artymowicz A, Douglas C, Cockerham K. The role of ophthal-mology in tele-stroke consults for triaging acute vision loss[J]. Open Access Emerg Med, 2024,16:45-56.